Schedule of Information about Stock Options Outstanding (Details) - $ / shares |
3 Months Ended | |
|---|---|---|
Mar. 29, 2025 |
Dec. 28, 2024 |
|
| Share-Based Payment Arrangement [Abstract] | ||
| Range of exercise prices | $ 0.95 | |
| Number of option shares, outstanding | 250,000 | 250,000 |
| Weighted average remaining life (in years) | 1 year 9 months | |
| Weighted average exercise price | $ 0.95 | |
| Number of exercisable | 250,000 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award. No definition available.
|
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|